Previous close | 82.17 |
Open | 81.83 |
Bid | 80.71 x 0 |
Ask | 80.96 x 0 |
Day's range | 81.83 - 81.83 |
52-week range | 58.34 - 88.06 |
Volume | |
Avg. volume | 1 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 24 Jul 2024 - 29 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Edwards Lifesciences ( NYSE:EW ) First Quarter 2024 Results Key Financial Results Revenue: US$1.60b (up 9.5% from 1Q...
Edwards Lifesciences stock underperformed its peers on Friday, sliding on light sales of its transcatheter aortic heart-valve replacements.
Lantheus' (LNTH) first-quarter results are likely to reflect solid top-line performance on the back of robust product adoption.